Progenics Pharmaceuticals Inc. (PGNX) Stock News, Earnings & History

(NASDAQ:PGNX) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 11.00
52wk low: 1.41
EPS: -0.87
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 212.71M
Avg Vol (3m): 478,698

Insider Trading Cheat Sheet

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Baker Mark Robert CEO Dec 26 Buy 3.01 1,142 3,437 158,014 Dec 26 01:05 PM
Baker Mark Robert CEO Nov 28 Buy 2.13 1,607 3,419 156,872 Nov 30 12:07 PM
Baker Mark Robert CEO Nov 19 Buy 1.96 11,800 23,104 155,265 Nov 20 01:41 PM
Baker Mark Robert CEO Nov 16 Buy 1.82 49,793 90,723 143,465 Nov 19 01:50 PM
Baker Mark Robert CEO Nov 15 Buy 1.69 48,833 82,332 93,672 Nov 16 01:54 PM
Baker Mark Robert CEO Oct 24 Buy 2.96 1,162 3,434 44,839 Oct 25 11:34 AM
Baker Mark Robert CEO Aug 22 Buy 4.23 815 3,451 42,641 Aug 23 09:44 AM
Baker Mark Robert CEO Jul 25 Buy 10.04 346 3,473 41,826 Jul 26 11:42 AM
ISRAEL ROBERT J Senior VP Medical Affairs Jul 02 Option Exercise 5.33 1,000 5,330 36,050 Jul 03 01:19 PM
ISRAEL ROBERT J Senior VP Medical Affairs Jul 02 Sale 9.79 1,000 9,790 35,050 Jul 03 01:19 PM
Yahoo, HV, Market Watch, The Wall St. Journal